As of 2025-12-14, the Relative Valuation of Syndax Pharmaceuticals Inc (SNDX) is (61.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.37 USD, the upside of Syndax Pharmaceuticals Inc based on Relative Valuation is -400.8%.
The range of the Relative Valuation is (43.28) - (71.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 20.0x | 17.0x |
| Forward P/E multiples | 12.1x - 24.3x | 17.2x |
| Fair Price | (43.28) - (71.52) | (61.27) |
| Upside | -312.5% - -451.1% | -400.8% |
| Date | P/E |
| 2025-12-05 | -5.67 |
| 2025-12-04 | -5.51 |
| 2025-12-03 | -5.50 |
| 2025-12-02 | -5.24 |
| 2025-12-01 | -5.34 |
| 2025-11-28 | -5.53 |
| 2025-11-26 | -5.55 |
| 2025-11-25 | -5.43 |
| 2025-11-24 | -5.51 |
| 2025-11-21 | -4.87 |
| 2025-11-20 | -4.76 |
| 2025-11-19 | -4.66 |
| 2025-11-18 | -4.77 |
| 2025-11-17 | -4.79 |
| 2025-11-14 | -4.64 |
| 2025-11-13 | -4.65 |
| 2025-11-12 | -4.69 |
| 2025-11-11 | -4.95 |
| 2025-11-10 | -4.39 |
| 2025-11-07 | -4.20 |
| 2025-11-06 | -4.10 |
| 2025-11-05 | -4.21 |
| 2025-11-04 | -4.28 |
| 2025-11-03 | -3.84 |
| 2025-10-31 | -3.82 |
| 2025-10-30 | -3.74 |
| 2025-10-29 | -3.69 |
| 2025-10-28 | -3.77 |
| 2025-10-27 | -3.66 |
| 2025-10-24 | -3.78 |
| 2025-10-23 | -4.10 |
| 2025-10-22 | -4.22 |
| 2025-10-21 | -4.24 |
| 2025-10-20 | -4.35 |
| 2025-10-17 | -3.99 |
| 2025-10-16 | -4.20 |
| 2025-10-15 | -4.20 |
| 2025-10-14 | -4.27 |
| 2025-10-13 | -4.24 |
| 2025-10-10 | -4.48 |
| 2025-10-09 | -4.52 |
| 2025-10-08 | -4.60 |
| 2025-10-07 | -4.59 |
| 2025-10-06 | -4.58 |
| 2025-10-03 | -4.35 |
| 2025-10-02 | -4.31 |
| 2025-10-01 | -4.38 |
| 2025-09-30 | -4.29 |
| 2025-09-29 | -4.34 |
| 2025-09-26 | -4.38 |